Certara Launches Its Simcyp In Vitro Data Analysis Toolkit
This new standalone solution is designed to meet the needs of early-stage drug discovery and development researchers.
Certara®, the global biosimulation technology-enabled drug development company, announced the launch of its Simcyp In Vitro (Data) Analysis (SIVA) Toolkit, version 1.0. The SIVA Toolkit is designed to enable the analysis of complex in vitro studies, including those with whole cells, tissue samples and solid dosage forms. It combines model-based data analysis approaches to assess the metabolism, transport or dissolution/solubility of drugs with optimization algorithms in a statistical environment. This approach ensures that users do not need to have extensive modeling or statistical experience to use the toolkit.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
